NIVF Valuation

NewGenIvf Group Ltd

Add to Watchlist

Advanced Chart

0.520

-0.028(-5.109%)1D

Overview
Forecast
Valuation
Earnings

NIVF Relative Valuation

NIVF's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NIVF is overvalued; if below, it's undervalued.

Historical Valuation

NewGenIvf Group Ltd (NIVF) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NewGenIvf Group Ltd (NIVF) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.52

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

-0.06

P/B

Median3y

3.27

Median5y

2.97

-347.91

FCF Yield

Median3y

-85.85

Median5y

-77.76

Competitors Valuation Multiple

The average P/S ratio for NIVF's competitors is 0.47, providing a benchmark for relative valuation. NewGenIvf Group Ltd Corp (NIVF) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -16.18%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap